#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant fibrous histiocytoma Autoimmune demyelinating disease Arteriosclerosis Hereditary angioedema with C1 esterase inhibitor deficiency Pulmonary tuberculosis Haemophilia B with anti factor IX Bronchopulmonary dysplasia Anal cancer recurrent Sexually transmitted disease B-cell lymphoma recurrent Alpha-1 antitrypsin deficiency Anal cancer Short stature Pancreatic neuroendocrine tumour Chorioretinitis More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II – Basic Information Piriformis syndrome Congenital nephrogenic diabetes insipidus – Diagnostics Alagille syndrome – Diagnostics Medulloblastoma recurrent Hypereosinophilic syndrome – Basic Information Lymphangioma – Trials in Disease Waldenstrom’s macroglobulinaemia – Basic Information Langerhans cell sarcoma – Basic Information Haemophilia A with anti factor VIII – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dabrafenib Cemiplimab Human Normal Immunoglobulin Dapirolizumab Pegol Ramipril Epirubicin [18F] CANAGLIFLOZIN RNMB3 Patiromer Elezanumab Bezafibrate Bi 3032950 Paracetamol Peboctocogene Camaparvovec Paroxetine Hydrochloride Isosorbide Dinitrate Meropenem Trihydrate Ozanimod Hydrochloride AGANIRSEN D5-Ethyl-Beta-D-Glucuronide More therapies…

    Learn about Your Condition

    Peripheral artery angioplasty Bacterial infection Depression Naevoid melanoma Febrile neutropenia Bacterial prostatitis Genital infection female Ophthalmoplegia Progressive multiple sclerosis Squamous cell carcinoma Cerebral amyloid angiopathy Weaning failure Diabetic foot infection Epileptic encephalopathy Ependymoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Psoriasis

  • Study on the Effectiveness and Safety of HRO350 for Patients with Mild-to-Moderate Psoriasis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Pehero
    • Betamethasone Valerate
    Finland Germany Norway Poland

  • Study on the Effects of Guselkumab on Memory T-Cells in Psoriasis Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Guselkumab
    Denmark

  • Study of Risankizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Ustekinumab
    • Risankizumab
    Germany Poland Spain

  • Study on the Effectiveness and Safety of DC-806 for Adults with Moderate to Severe Plaque Psoriasis

    Not recruiting

    2 1
    Investigated Drugs:
    • Dc-806
    Czechia Germany Hungary Poland Spain

  • Study on Long-term Safety of Apremilast in Children Aged 6-17 with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Belgium Czechia Italy Spain
Previous Page
1 … 7 8 9

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!